Matches in Wikidata for { <http://www.wikidata.org/entity/Q91317798> ?p ?o ?g. }
Showing items 1 to 45 of
45
with 100 items per page.
- Q91317798 description "artículu científicu espublizáu en xineru de 2019" @default.
- Q91317798 description "scientific article published on 31 January 2019" @default.
- Q91317798 description "wetenschappelijk artikel" @default.
- Q91317798 description "наукова стаття, опублікована 31 січня 2019" @default.
- Q91317798 name "Vedolizumab has no efficacy on articular manifestations in patients with spondyloarthritis associated with inflammatory bowel disease" @default.
- Q91317798 name "Vedolizumab has no efficacy on articular manifestations in patients with spondyloarthritis associated with inflammatory bowel disease" @default.
- Q91317798 type Item @default.
- Q91317798 label "Vedolizumab has no efficacy on articular manifestations in patients with spondyloarthritis associated with inflammatory bowel disease" @default.
- Q91317798 label "Vedolizumab has no efficacy on articular manifestations in patients with spondyloarthritis associated with inflammatory bowel disease" @default.
- Q91317798 prefLabel "Vedolizumab has no efficacy on articular manifestations in patients with spondyloarthritis associated with inflammatory bowel disease" @default.
- Q91317798 prefLabel "Vedolizumab has no efficacy on articular manifestations in patients with spondyloarthritis associated with inflammatory bowel disease" @default.
- Q91317798 P1433 Q91317798-DEE5004C-5AF0-49E2-AA16-4F56FBC31568 @default.
- Q91317798 P1476 Q91317798-A88B704D-ECC2-40E2-BBFF-FAF96CFB8E9B @default.
- Q91317798 P2093 Q91317798-1F96A8CF-9778-44E5-B313-AA988E8DE428 @default.
- Q91317798 P2093 Q91317798-3CAA791F-6773-4FD1-B0B1-B6D6AE277489 @default.
- Q91317798 P2093 Q91317798-76FBE928-0EC3-43CB-905A-CE17179553D7 @default.
- Q91317798 P2093 Q91317798-7D2484B6-6F14-4831-B50F-951418168B3B @default.
- Q91317798 P2093 Q91317798-9137434A-D776-4E72-9B5F-21540D61D615 @default.
- Q91317798 P2093 Q91317798-A882291E-7AEF-4E29-AC78-5158D3D197E4 @default.
- Q91317798 P304 Q91317798-3DE4B2D6-52C1-4F3A-B2C1-D37117E10AD1 @default.
- Q91317798 P31 Q91317798-08354F08-3208-4275-94C4-F19AC6C62A46 @default.
- Q91317798 P356 Q91317798-770F5A4C-CB60-4B12-B8BE-7CE1A13F1E6B @default.
- Q91317798 P433 Q91317798-C015AB2A-1D4C-4C24-8DA0-E09020505BD6 @default.
- Q91317798 P478 Q91317798-9DC42543-E70F-4F95-9124-08CB4D704292 @default.
- Q91317798 P577 Q91317798-6F448BB0-756F-48AB-9AF7-0955B791AE95 @default.
- Q91317798 P698 Q91317798-C815B80E-466C-4489-B5E5-9C1398423F8E @default.
- Q91317798 P921 Q91317798-571E423C-753E-48A2-8E7E-23FD1BD7E568 @default.
- Q91317798 P356 J.JBSPIN.2019.01.008 @default.
- Q91317798 P698 30711690 @default.
- Q91317798 P1433 Q15752403 @default.
- Q91317798 P1476 "Vedolizumab has no efficacy on articular manifestations in patients with spondyloarthritis associated with inflammatory bowel disease" @default.
- Q91317798 P2093 "Benjamin Pariente" @default.
- Q91317798 P2093 "Cédric Duchemin" @default.
- Q91317798 P2093 "Julien Paccou" @default.
- Q91317798 P2093 "Maria Nachury" @default.
- Q91317798 P2093 "Pierre Desreumaux" @default.
- Q91317798 P2093 "René-Marc Flipo" @default.
- Q91317798 P304 "654-656" @default.
- Q91317798 P31 Q13442814 @default.
- Q91317798 P356 "10.1016/J.JBSPIN.2019.01.008" @default.
- Q91317798 P433 "5" @default.
- Q91317798 P478 "86" @default.
- Q91317798 P577 "2019-01-31T00:00:00Z" @default.
- Q91317798 P698 "30711690" @default.
- Q91317798 P921 Q917447 @default.